Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-Coding RNAs and Hepatitis C Virus-Induced Hepatocellular Carcinoma
Marie‐Laure Plissonnier, Katharina Herzog, Massimo Levrero, et al.
Viruses (2018) Vol. 10, Iss. 11, pp. 591-591
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification
Saranya Chidambaranathan Reghupaty, Paul B. Fisher, Devanand Sarkar
Advances in cancer research (2020), pp. 1-61
Open Access | Times Cited: 619
Mechanisms Underlying Hepatitis C Virus-Associated Hepatic Fibrosis
Mousumi Khatun, Ratna B. Ray
Cells (2019) Vol. 8, Iss. 10, pp. 1249-1249
Open Access | Times Cited: 159
<p>Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment</p>
Srikanta Dash, Yücel Aydın, Kyle E Widmer, et al.
Journal of Hepatocellular Carcinoma (2020) Vol. Volume 7, pp. 45-76
Open Access | Times Cited: 92
Hepatitis C Virus and Hepatocellular Carcinoma: When the Host Loses Its Grip
Kaku Goto, Armando Andres Roca Suarez, Florian Wrensch, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3057-3057
Open Access | Times Cited: 78
A Comprehensive Insight and In Silico Analysis of CircRNAs in Hepatocellular Carcinoma: A Step toward ncRNA-Based Precision Medicine
R.A. Youness, Hossam A. Hassan, Tasneem Abaza, et al.
Cells (2024) Vol. 13, Iss. 15, pp. 1245-1245
Open Access | Times Cited: 9
Role of Virus-Induced Host Cell Epigenetic Changes in Cancer
Valeria Pietropaolo, Carla Prezioso, Ugo Moens
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8346-8346
Open Access | Times Cited: 50
Hepatitis C virus associated hepatocellular carcinoma
Mousumi Khatun, Ranjit Ray, Ratna B. Ray
Advances in cancer research (2020), pp. 103-142
Closed Access | Times Cited: 34
Molecular pathways in viral hepatitis-associated liver carcinogenesis: An update
Gülsüm Özlem Elpek
World Journal of Clinical Cases (2021) Vol. 9, Iss. 19, pp. 4890-4917
Open Access | Times Cited: 26
<p>LncRNA GAS5-mediated miR-1323 promotes tumor progression by targeting TP53INP1 in hepatocellular carcinoma</p>
Fengjuan Zhang, Chao Yang, Zhiyuan Xing, et al.
OncoTargets and Therapy (2019) Vol. Volume 12, pp. 4013-4023
Open Access | Times Cited: 27
Inhibition of Long Noncoding RNA Linc‐Pint by Hepatitis C Virus in Infected Hepatocytes Enhances Lipogenesis
Mousumi Khatun, Subhayan Sur, Robert Steele, et al.
Hepatology (2020) Vol. 74, Iss. 1, pp. 41-54
Open Access | Times Cited: 25
Viral hepatitis as a risk factor for the development of hepatocellular carcinoma
Saleh A. Alqahtani, Massimo Colombo
Hepatoma Research (2020) Vol. 2020
Open Access | Times Cited: 22
Host Epigenetic Alterations and Hepatitis B Virus-Associated Hepatocellular Carcinoma
Mirjam B. Zeisel, Francesca Guerrieri, Massimo Levrero
Journal of Clinical Medicine (2021) Vol. 10, Iss. 8, pp. 1715-1715
Open Access | Times Cited: 17
Long non-coding RNAs (LncRNAs), viral oncogenomics, and aberrant splicing events: therapeutics implications.
Rodney Hull, Zukile Mbita, Zodwa Dlamini
American Journal of Cancer Research (2021) Vol. 11, Iss. 3, pp. 866-883
Closed Access | Times Cited: 16
SNORD126 Promotes Hepatitis C Virus Infection by Upregulating Claudin-1 via Activation of PI3K-AKT Signaling Pathway
Xijing Qian, Chen Xu, Bingan Wu, et al.
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 17
MicroRNAs Improve Cancer Treatment Outcomes Through Personalized Medicine
Saeid Hatam
MicroRNA (2023) Vol. 12, Iss. 2, pp. 92-98
Closed Access | Times Cited: 5
Artificial intelligence-based prediction of molecular and genetic markers for hepatitis C–related hepatocellular carcinoma
Cemil Çolak, Zeynep Küçükakçalı, Sami Akbulut
Annals of Medicine and Surgery (2023) Vol. 85, Iss. 10, pp. 4674-4682
Open Access | Times Cited: 5
Long noncoding RNA LINC01189 is associated with HCV-hepatocellular carcinoma and regulates cancer cell proliferation and chemoresistance through hsa-miR-155-5p
Ying Yao, Shu Fang, Fang Wang, et al.
Annals of Hepatology (2020) Vol. 22, pp. 100269-100269
Open Access | Times Cited: 13
Role of Genetic and Epigenetic Modifications in the Progression of Hepatocellular Carcinoma in Chronic HCV Patients
Anum Syyam, Hira Raheem Akbar, Zuzana Macek Jílková, et al.
Livers (2023) Vol. 3, Iss. 1, pp. 82-92
Open Access | Times Cited: 4
Leveraging metformin to combat hepatocellular carcinoma: its therapeutic promise against hepatitis viral infections
Ali Shojaeian, Mohsen Nakhaie, Zahra Sobhi Amjad, et al.
Journal of Cancer Metastasis and Treatment (2024)
Open Access | Times Cited: 1
Hepatitis C virus Core overcomes all-trans retinoic acid-induced apoptosis in human hepatoma cells by inhibiting p14 expression via DNA methylation
Juri Kwak, Jung‐Hye Choi, Kyung Lib Jang
Oncotarget (2017) Vol. 8, Iss. 49, pp. 85584-85598
Open Access | Times Cited: 7
Addressing the Challenges of Hepatitis C Cure and Persistent Risk of Hepatocellular Carcinoma
Thomas F. Baumert, Yujin Hoshida
Viruses (2019) Vol. 11, Iss. 5, pp. 441-441
Open Access | Times Cited: 7
Prognostic Value of a Novel Signature With Nine Hepatitis C Virus-Induced Genes in Hepatic Cancer by Mining GEO and TCGA Databases
Jianming Wei, Bo Wang, Xibo Gao, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 7
Construction of novel lncRNA-miRNA-mRNA ceRNA networks associated with prognosis of hepatitis C virus related hepatocellular carcinoma
Lishi Shao, Lei Liang, Qixiang Fang, et al.
Heliyon (2022) Vol. 8, Iss. 10, pp. e10832-e10832
Open Access | Times Cited: 4
Exploring the mechanism of resistance to sorafenib in two hepatocellular carcinoma cell lines
Zhi Zhang, Cheng-Zu He, Yaqin Qin, et al.
Aging (2020) Vol. 12, Iss. 23, pp. 24255-24269
Open Access | Times Cited: 5
Noncoding RNAs in hepatitis: Unraveling the apoptotic pathways
Khalid Saad Alharbi
Pathology - Research and Practice (2024) Vol. 255, pp. 155170-155170
Closed Access
Page 1 - Next Page

Scroll to top